2XF0:
reference: Design and evaluation of 3,6-di(hetero)aryl imidazo[1,2-a]pyrazines as inhibitors of checkpoint and other kinases., Matthews TP, McHardy T, Klair S, Boxall K, Fisher M, Cherry M, Allen CE, Addison GJ, Ellard J, Aherne GW, Westwood IM, Montfort RV, Garrett MD, Reader JC, Collins I, Bioorg Med Chem Lett. 2010 May 27. PMID: 20561787

This OCA Structure page
uses Jmol, developed by the Jmol Development Team (documentation).